People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Senti Biosciences, Inc. | — | Biotechnology | Series B | $77.0M | $221.8M | 2018 |
| Little Bean & Little Stone Ltd Liability Co | — | Other | Series B | $20.0M | $147.8M | 2023 |
| Little Stone Ltd Liability Co | — | Other | Seed | $4.0M | $72.7M | 2020 |
| LifeLoop, LLC | — | Other Technology | Pre-Seed | $1.0M | $1.6M | — |
Philip Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rob Minkoff | 2 | 2 |
| Edward Mathers | 1 | 12 |
| Ed Mathers | 1 | 11 |
| Amy Johnson | 1 | 9 |
| James Collins | 1 | 8 |
| Alex Kolicich | 1 | 8 |
| Kent Johnson | 1 | 6 |
| Timothy Lu | 1 | 2 |
| Donald Tang | 1 | 2 |
| Fran Schulz | 1 | 1 |
| Brenda Cooperstone | 1 | 1 |
| Yvonne Li | 1 | 1 |
| Kanya Rajangam | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.